Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal potassium (K+) channels represent a diverse group of ion channels, including KCa3.1, KCNQ1, and BK channels, that are expressed in the epithelial and smooth muscle cells of the gastrointestinal tract. These channels are fundamental to intestinal physiology, as they maintain the negative membrane potential required to drive the secretion of chloride ions and water into the intestinal lumen (He et al., 2011, PubMed: 21835910). In the epithelium, basolateral K+ recycling via channels like KCa3.1 and KCNQ1/KCNE3 is essential for sustained fluid secretion (Devor et al., 1996, PubMed: 8939873). Dysregulation of these channels is a hallmark of various gastrointestinal pathologies; for instance, their overactivation is a primary driver of secretory diarrhea, while their dysfunction can contribute to impaired motility and inflammatory bowel disease. Consequently, these channels are significant therapeutic targets, with inhibitors like Senicapoc being investigated for their ability to reduce excessive fluid loss in diarrheal conditions (Ataga et al., 2008, PubMed: 18216214). However, targeting these channels requires high specificity to avoid systemic side effects, such as cardiac arrhythmias or neurological disturbances, due to the widespread expression of K+ channel homologs in other tissues.
Modulation of potassium ion efflux to regulate the electrochemical gradient for transepithelial fluid transport and smooth muscle contractility.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal potassium channel (K+ channel).